Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2080221964Phase 1
Phase 1, open-label, single-arm trial of bitopertin, sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoint: Primary pharmacokinetic interaction endpoints.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2080221964.